论文部分内容阅读
血管紧张素转换酶抑制药(ACEI)和血管紧张素Ⅱ受体1拮抗药(ARB)是目前抑制肾素-血管紧张素系统的主要药物大量研究结果表明ACEI和ARB不仅可降低糖尿病的发生率、延迟糖尿病的进展,而且可降低糖尿病患者心血管事件的发生率和心血管死亡率。本文对其作用及机制进行探讨
Angiotensin-Converting Enzyme Inhibitors (ACEIs) and Angiotensin II Receptor-1 Antagonists (ARBs) are the major drugs currently inhibiting the renin-angiotensin system. A large number of studies have shown that ACEI and ARB not only reduce the incidence of diabetes , Delay the progression of diabetes and reduce the incidence of cardiovascular events and cardiovascular mortality in diabetic patients. This article discusses its role and mechanism